We are live on
!
Find out more
Eli Lilly
3,270 hedge funds and large institutions have $464B invested in Eli Lilly in 2023 Q4 according to their latest regulatory filings, with 438 funds opening new positions, 1,218 increasing their positions, 1,234 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% less funds holding in top 10
Funds holding in top 10: 306 → 305 (-1)
1% less repeat investments, than reductions
Existing positions increased: 1,218 | Existing positions reduced: 1,234
10% less call options, than puts
Call options by funds: $4.99B | Put options by funds: $5.55B
Holders
3,270
Holding in Top 10
305
Calls
$4.99B
Puts
$5.55B
Top Buyers
| 1 | +$7.46B | |
| 2 | +$2.1B | |
| 3 | +$604M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$534M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$384M |
Top Sellers
| 1 | -$763M | |
| 2 | -$627M | |
| 3 | -$599M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$504M |
| 5 |
Jennison Associates
New York
|
-$473M |